Sequence Similarity Clusters for the Entities in PDB 3V6F

Entity #1 | Chains: A,C,E,H
Fab e6 Heavy Chain protein, length: 224 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 14373
95 % 1 2 14578 Flexibility: Low
Max RMSD: 1.7, Avg RMSD: 1.2
PDBFlex
90 % 1 2 14293
70 % 1206 2706 2
50 % 2488 5577 1
40 % 2852 6322 1
30 % 3458 7862 1
Entity #2 | Chains: B,D,F,L
Fab e6 Light Chain protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 15995
95 % 2 3 11063 Flexibility: Low
Max RMSD: 2.2, Avg RMSD: 1.1
PDBFlex
90 % 45 91 288
70 % 1215 2747 1
50 % 2489 5577 1
40 % 2853 6322 1
30 % 3459 7862 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
3 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
4 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
5 5IVN 1 A BC2-nanobody 30538
6 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
7 5E7B 1 A nanobody nano-L06 9838
8 2P45 2 B ANTIBODY CAB-RN05 9838
9 2X1Q 1 A, B GELSOLIN NANOBODY 9844
10 5U64 1 B VHH-28 9838
11 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
12 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
13 4B41 1 A, B ANTIBODY G7 9844
14 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
15 4NZU 1 L 13PL heavy chain Fab 9606
16 4NZU 2 H 13PL light chain Fab 9606
17 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
18 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
19 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
20 5IMM 1 B Nanobody 9835
21 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
22 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
23 5NLU 1 A single domain llama antibody Nb36 9844
24 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
25 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
27 1MEX 1 L Fab 29G12 light chain 10090
28 1MEX 2 H Fab 29G12 heavy chain 10090
29 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
30 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
31 5IMK 1 B Nanobody 9835
32 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
33 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
34 6CWK 1 A Anti-Ricin antibody 30538
35 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
36 6EH4 2 E Human T Cell Receptor Beta Chain 9606
37 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
38 4BUH 1 A, B CLONE M0418 SCFV 9606
39 4B50 1 A 2H10 LLAMA VHH 9844
40 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
41 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
42 6FR4 1 A TCR 003 alpha chain 9606
43 6FR4 2 B TCR 003 Beta Chain 9606
44 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
45 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
46 6DBA 1 A, B nanobody VHH R303 9838
47 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
48 6EH5 2 B Human T Cell Receptor Beta Chain 9606
49 5YD4 1 A, C, E, G scFv 4B08 10090
50 5YD3 1 A, C, E, G scFv 4B08 10090
51 2XT1 2 B CAMELID VHH 9 30538
52 5UD9 1 H Fab heavy chain 9606
53 5UD9 2 L Light chain 9606
54 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
55 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
56 4P48 1 A Antibody scFv 180 9031
57 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
58 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
59 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
60 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
61 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
62 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
63 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
64 6FR3 1 A 003 TCR Alpha Chain 9606
65 6FR3 2 B 003 TCR Beta Chain 9606
66 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
67 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
68 5J1S 3 C VHH domain BS-2 30538
69 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
70 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
71 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
72 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
73 6MEE 2 B, D antibody HEPC74 Light Chain 9606
74 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
75 6BJZ 1 H 5c8 Fab Heavy chain 9606
76 6BJZ 2 L 5c8 Fab Light chain 9606
77 5L6Q 1 A, B H5AL 9606
78 5J1T 3 C VHH domain BS-2 30538
79 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
80 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
81 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
82 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
83 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
84 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
85 4XCF 1 L 4E10 Fab light chain 9606
86 4XCF 2 H 4E10 Fab heavy chain 9606
87 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
88 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
89 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
90 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
91 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
92 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
93 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
94 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
95 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
96 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
97 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
98 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
99 5X08 1 H Fab 4E10 Heavy chain 9606
100 5X08 2 L Fab 4E10 Light chain 9606
101 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
102 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
103 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
104 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
105 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
106 6MEG 1 H antibody HEPC46 Heavy Chain 9606
107 6MEG 2 L antibody HEPC46 Light Chain 9606
108 2X1O 1 A, B GELSOLIN NANOBODY 9844
109 4QGY 1 A, B nanobody n25, VH domain 9844
110 5C2B 1 H scFv 3B4 heavy chain 9606
111 5C2B 2 L 3B4 light chain 9606
112 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
113 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
114 4XAW 1 L 4E10 Fab light chain 9606
115 4XAW 2 H 4E10 Fab heavy chain 9606
116 5VNV 1 A Nb.b201 32630
117 4P49 1 A Antibody scFv B8 9031
118 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
119 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
120 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
121 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
122 5DXW 1 A PD-L1 nanobody 9835
123 2NW2 1 A ELS4 TCR alpha chain 9606
124 2NW2 2 B ELS4 TCR beta chain 9606
125 5UCB 1 H Fab Heavy Chain 9606
126 5UCB 2 L Fab Light Chain 9606
127 3T0W 1 A, B immunoglobulin variable lambda domain 9606
128 2VXV 1 H HUMAN IGG ABT-325 9606
129 2VXV 2 L HUMAN IGG ABT-325 9606
130 4N9O 2 B Nanobody Nb484 Nb484 9844
131 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
132 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
133 3T0V 1 A immunoglobulin variable lambda domain 9606
134 4GXV 1 H, I Antibody 1F1, heavy chain 9606
135 4GXV 2 L, M Antibody 1F1, light chain 9606
136 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
137 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
138 2VXT 1 H MURINE IGG 125-2H 10090
139 2VXT 3 L MURINE IGG 125-2H 10090
140 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
141 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
142 1T2J 1 A M12-Variable Heavy domain 9606
143 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
144 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
145 6DBF 2 B InlB specific VHH R303 9838
146 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
147 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
148 6DBG 2 C, D VHH R303 9838
149 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
150 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
151 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
152 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
153 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
154 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
155 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
156 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
157 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
158 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
159 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
160 5W24 1 L 5C4 Fab Light Chain 10090
161 5W24 2 H 5C4 Fab Heavy Chain 10090
162 4HPY 1 H CH59 Fab heavy chain 9606
163 4HPY 2 L CH59 Fab light chain 9606
164 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
165 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
166 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
167 5VM6 1 A single domain camelid nanobody VHH T10 9844
168 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
169 4JG1 1 L Fab light chain 9606
170 4JG1 2 H Fab heavy chain 9606
171 1SQ2 2 N novel antigen receptor 7801
172 6E65 1 L TB31F Fab light chain 9606
173 6E65 2 H TB31F Fab heavy chain 9606
174 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
175 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
176 4KML 2 B Nanobody 9844
177 5VF2 1 A scFv 2D10 10090
178 5I8C 1 A VRC34.01 Fab heavy chain 9606
179 5I8C 2 B VRC34.01 Fab light chain 9606
180 4O5L 1 L Fab F045-092 light chain 9606
181 4O5L 2 H Fab F045-092 heavy chain 9606
182 5MYX 1 A, C Fab c#24 light chain 10090
183 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
184 4Z9K 2 B VHH2(F5) antibody 30538
185 3IFL 1 L 12A11 FAB antibody light chain 10090
186 3IFL 2 H 12A11 FAB antibody heavy chain 10090
187 5WK2 1 L M116 LIGHT CHAIN 9606
188 5WK2 2 H M116 HEAVY CHAIN FD 9606
189 3PP4 1 H GA101 Fab heavy chain 10090
190 3PP4 2 L GA101 Fab light chain 10090
191 3KDM 1 A, L Immunoglobulin light chain 9606
192 3KDM 2 B, H Immunoglobulin heavy chain 9606
193 5NIV 1 A Light chain of 5D3 Fab 10090
194 5NIV 2 B Heavy chain of 5D3 Fab 10090
195 5N4J 1 L LIGHT CHAIN 9606
196 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
197 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
198 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
199 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
200 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
201 5X4G 1 A 6H8 Fab heavy chain 10090
202 5X4G 2 B 6H8 Fab light chain 10090
203 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
204 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
205 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
206 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
207 4PTU 1 A Antibody pn132p2C05, light chain 9606
208 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
209 4TPR 1 L If kappa light chain 10090
210 4TPR 2 H Fab heavy chain 10090
211 5LMW 1 A Nanobody 9844
212 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
213 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
214 3IFN 1 H 12A11 FAB antibody heavy chain 10090
215 3IFN 2 L 12A11 FAB antibody light chain 10090
216 5U3P 1 H DH511.4 Fab Heavy Chain 9606
217 5U3P 2 L DH511.4 Fab Light Chain 9606
218 6BLA 1 H AMM01 Fab Heavy chain 9606
219 6BLA 2 L AMM01 Fab Light chain 9606
220 5NM0 1 A, B, C, D Nb36 9844
221 4TOY 1 H 35O22 Fab Heavy chain 9606
222 4TOY 2 L 35O22 Fab Light chain 9606
223 6H6Y 2 E, F, G, H Nanobody (VHH) Nano-7 30538
224 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
225 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
226 3NPS 2 B S4 FAB HEAVY CHAIN 9606
227 3NPS 3 C S4 FAB LIGHT CHAIN 9606
228 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
229 5I4F 1 A scFv 2D10 10090
230 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
231 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
232 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
233 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
234 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
235 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
236 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
237 5WN9 1 H scFv 2D10 9606
238 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
239 4XC3 1 L 4E10 Fab light chain 9606
240 4XC3 2 H 4E10 Fab heavy chain 9606
241 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
242 4PPT 1 A Engineered single domain VHH antibody 9844
243 3R0M 1 A, B Llama VHH A12 9844
244 4M5Y 1 H, I Fab 5J8 heavy chain 9606
245 4M5Y 2 L, M Fab 5J8 light chain 9606
246 4TQE 1 L If kappa light chain 10090
247 4TQE 2 H Fab heavy chain 10090
248 3ZKQ 2 D XA4813 9844
249 5YY4 1 A scFv 4B08 10090
250 4I13 2 B Protein ca1697 (nanobody) 9844
251 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
252 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
253 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
254 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
255 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
256 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
257 5C2U 1 B Nanobody Nanobody 9838
258 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
259 5VSI 2 L CH1/Ckappa Fab light chain 9606
260 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
261 1XFP 1 A heavy chain antibody VHH domain 9838
262 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
263 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
264 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
265 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
266 5JXA 1 H VRC03 Heavy chain 9606
267 5JXA 2 L VRC03 Light chain 9606
268 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
269 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
270 4POY 1 A VHH-metal 9844
271 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
272 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
273 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
274 5NLW 1 A nanobody Nb36 9844
275 3CDC 1 A, B Light Chain Amyloidogenic 9606
276 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
277 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
278 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
279 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
280 3NTC 1 L Fab light chain 10090
281 3NTC 2 H Fab heavy chain 10090
282 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
283 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
284 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
285 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
286 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
287 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
288 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
289 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
290 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
291 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
292 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
293 6BE3 1 H Fab (F598) Heavy Chain 9606
294 6BE3 2 L Fab (F598) Light Chain 9606
295 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
296 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
297 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
298 3G9A 2 B Minimizer 9838
299 4NWU 1 H APE1551 Ab Fab heavy chain 9606
300 4NWU 2 L APE1551 Ab Fab light chain 9606
301 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
302 1KGC 1 D T-cell receptor alpha chain 9606
303 1KGC 2 E T-cell receptor beta chain 9606
304 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
305 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
306 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
307 6FRC 2 B Human T-Cell Receptor beta Chain 9606
308 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
309 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
310 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
311 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
312 5EWI 1 H VRC38.01 Heavy Chain 9606
313 5EWI 2 L VRC38.01 Light Chain 9606
314 5E2W 1 L AT8 LIGHT CHAIN 10090
315 5E2W 2 H AT8 HEAVY CHAIN 10090
316 5MYK 1 A Fab c#17 light chain 10090
317 5MYK 2 B Fab c#17 heavy chain 10090
318 6FUQ 1 A Human F11 T-Cell Receptor 9606
319 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
320 4NZR 1 H PGT135 heavy chain Fab 9606
321 4NZR 2 L PGT135 light chain Fab 9606
322 5MYO 1 A, C Fab c#6 light chain 10090
323 5MYO 2 B, D Fab c#6 heavy chain 10090
324 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
325 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
326 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
327 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
328 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
329 5UEL 1 H 354NC102 Fab Heavy Chain 9606
330 5UEL 2 L 354NC102 Fab Light Chain 9606
331 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
332 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
333 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
334 2P43 2 B ANTIBODY CAB-RN05 9838
335 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
336 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
337 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
338 5E2V 1 L AT8 LIGHT CHAIN 10090
339 5E2V 2 H AT8 HEAVY CHAIN 10090
340 4KRN 1 A Nanobody/VHH domain EgA1 9844
341 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
342 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
343 4GFT 2 B Nanobody 9844
344 4TVS 2 a, b VHH Domain BS-1 30538
345 4W6Y 2 B Nanobody NbFedF9 9844
346 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
347 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
348 6EZW 1 B VHH antibody BCD090-M2 9844
349 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
350 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
351 5JUE 1 L light chain of UIC2 Fab 10090
352 5JUE 2 H heavy chain of UIC2 Fab 10090
353 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
354 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
355 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
356 1UAC 2 H Ig VH,anti-lysozyme 10090
357 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
358 5JR1 1 H 10E8 heavy chain 9606
359 5JR1 2 L 10E8 mature light chain 9606
360 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
361 6CA7 1 L PCT64_13C light chain 9606
362 6CA7 2 H PCT64_13C heavy chain 9606
363 5VF6 1 A single chain variable fragment 9031
364 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
365 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
366 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
367 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
368 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
369 6FR9 2 B T-Cell Receptor F11 beta chain 9606
370 5OB5 2 H fAb Heavy chain 9606
371 5OB5 3 L fAb Light chain 9606
372 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
373 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
374 5I66 1 A 8B6 antibody, heavy chain 10090
375 5I66 2 B 8B6 antibody, light chain 10090
376 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
377 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
378 6BZY 1 H 22D11 Heavy Chain 10090
379 6BZY 2 L 22D11 Light Chain 10090
380 3QQ9 1 C, L 101F LIGHT CHAIN 10090
381 3QQ9 2 D, H 101F HEAVY CHAIN 10090
382 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
383 5TKK 3 L mouse antibody vFP5.01 light chain 10090
384 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
385 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
386 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
387 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
388 5W6C 1 H UCA Fab heavy chain 9606
389 5W6C 2 L UCA Fab light chain 9606
390 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
391 5I1K 1 L FAB LIGHT CHAIN 9606
392 5I1K 2 H FAB HEAVY CHAIN 9606
393 3OZ9 1 L Fab NC-1 kappa light chain 10090
394 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
395 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
396 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
397 5V7U 1 L CBTAU-22.1 Fab light chain 9606
398 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
399 5UEA 1 A, H Fab Heavy Chain 9606
400 5UEA 3 B, L Fab Light Chain 9606
401 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
402 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
403 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
404 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
405 3G5Y 1 A 175 light chain 10090
406 3G5Y 2 B 175 heavy chain 10090
407 5O02 2 C Nanobody (VHH) Nano-4 30538
408 5NMV 1 L Fab light chain 10088
409 5NMV 2 H Fab heavy chain 10088
410 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
411 4N8C 2 L, M Light chain of monoclonal antibody 10090
412 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
413 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
414 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
415 4HGW 1 A Antibody Fab fragment, light chain 10090
416 4HGW 2 B Antibody Fab fragment, heavy chain 10090
417 1NLB 1 L antibody 19D9D6 light chain 10090
418 1NLB 2 H antibody 19D9D6 heavy chain 10090
419 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
420 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
421 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
422 3VFG 1 L 3F8 Light Chain 10090
423 3VFG 2 H 3F8 Heavy Chain 10090
424 4X7F 2 C, D Nano-25 Nanobody 30538
425 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
426 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
427 3QRG 1 L Fab light chain 9606
428 3QRG 2 H Fab heavy chain Fd fragment 9606
429 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
430 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
431 5M6A 1 A, B, C, D Bence-Jones light chain 9606
432 4LLY 2 B, D light chain Clambda 9606
433 4LGR 2 B Camelid nanobody (VHH3) 30538
434 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
435 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
436 5EZI 1 H Fab c12 heavy chain 9606
437 5EZI 2 L Fab c12 Light chain 9606
438 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
439 4K23 1 H anti-uPAR antibody, heavy chain 10090
440 4K23 2 L anti-uPAR antibody, light chain 10090
441 5J57 2 B VHH single chain antibody V5E1 30538
442 3NCJ 1 L Fab15 Mut8 light chain 9606
443 3NCJ 2 H Fab15 Mut8 heavy chain 9606
444 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
445 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
446 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
447 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
448 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
449 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
450 5W05 1 L M59 FAB LIGHT CHAIN 10090
451 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
452 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
453 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
454 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
455 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
456 5OMM 2 C Nanobody (VHH) Nano-14 30538
457 5E03 1 A CTLA-4 nanobody 9835
458 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
459 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
460 4M61 1 A, C Fab A52 light chain 10090
461 4M61 2 B, D Fab A52 heavy chain 10090
462 5YE3 1 B 2A7D9 VH CH1 chain 10090
463 5YE3 2 A 2A7D9 L chain 10090
464 5LZ0 1 A, B PorM nanobody 9844
465 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
466 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
467 1UM5 1 L Antibody 21H3 L chain 10090
468 1UM5 2 H Antibody 21H3 H chain 10090
469 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
470 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
471 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
472 4NWT 1 L APE1531 Ab Fab light chain 9606
473 4NWT 2 H APE1531 Ab Fab heavy chain 9606
474 6DBE 1 A, B nanobody VHH R303 9844
475 3WHX 1 A mAb Fab H fragment 10090
476 3WHX 2 B mAb Fab L fragment 10090
477 3NA9 1 L Fab15 light chain 9606
478 3NA9 2 H Fab15 heavy chain 9606
479 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
480 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
481 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
482 6FUO 2 B Human F11 T-Cell Receptor 9606
483 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
484 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
485 4LRI 1 A, B MSL-109 Light Chain 9606
486 4LRI 2 C, P MSL-109 Heavy Chain 9606
487 2XXC 1 B CAMELID VHH 9 30538
488 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
489 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
490 4JN2 1 A, L anti dabigatran Fab 10090
491 4JN2 2 B, H anti dabigatran Fab 10090
492 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
493 4XBE 2 H 4E10 Fab heavy chain 9606
494 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
495 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
496 6BE2 1 H Fab (F598) Heavy Chain 9606
497 6BE2 2 L Fab (F598) Light Chain 9606
498 3QYC 1 A, B VH domain of IgG molecule 9606
499 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
500 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
501 4JFZ 1 L Fab light chain 9606
502 4JFZ 2 H Fab heavy chain 9606
503 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
504 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
505 5VAK 2 B Nb914 Nanobody 9844
506 3WIF 1 A mAb Fab H fragment 10090
507 3WIF 2 B mAb Fab L fragment 10090
508 5U6A 1 A Light Chain 9606
509 5U6A 2 B Heavy Chain 9606
510 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
511 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
512 3MBX 1 L X836 LIGHT CHAIN 10090
513 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
514 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
515 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
516 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
517 2XXM 2 B CAMELID VHH 9 30538
518 6APC 1 H Epididymis luminal protein 214 9606
519 6APC 2 L IGL@ protein 9606
520 6BJ8 3 D TCR 55 alpha chain 9606
521 6BJ8 4 H TCR 55 beta chain 9606
522 5IR3 1 A Ig lambda chain V-VI region AR 9606
523 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
524 4HHA 1 A Fab KE5 Fab fragment KE5 9606
525 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
526 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
527 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
528 4RGO 2 H 14G8 heavy chain Fab 10090
529 4RGO 3 L 14G8 light chain Fab 10090
530 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
531 5GRY 1 A, G diabody 9606
532 5UEK 2 H Fab 12E Heavy Chain 9606
533 5UEK 3 L Fab 12E Light Chain 9606
534 3NAA 1 L Fab15 Mut5 light chain 9606
535 3NAA 2 H Fab15 Mut5 heavy chain 9606
536 6DBD 1 A, B, C, D nanobody VHH R326 9844
537 1Q0X 1 L Fab 9B1, light chain 10090
538 1Q0X 2 H Fab 9B1, heavy chain 10090
539 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
540 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
541 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
542 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
543 5JDS 1 B Nanobody 9835
544 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
545 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
546 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
547 5IK3 2 B, D 1E03 Fab fragment light chain 9606
548 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
549 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
550 5XLI 1 a, b FabL 10090
551 5XLI 2 c, d FabH 10090
552 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
553 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
554 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
555 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
556 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
557 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
558 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
559 4WUK 1 H CH65 heavy chain 9606
560 4WUK 2 L CH65 light chain 9606
561 5L8L 2 B New antigen receptor variable domain 168098
562 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
563 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
564 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
565 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
566 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
567 5JOP 1 D, L Fab 14.22 light chain 10090
568 5JOP 2 E, H Fab14.22 heavy chain 10090
569 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
570 4HPO 1 H CH58 Fab heavy chain 9606
571 4HPO 2 L CH58 Fab light chain 9606
572 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
573 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
574 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
575 5UKN 2 L DH522UCA Fab fragment light chain 9544
576 4AIZ 1 A, C, D V2-17 PROTEIN 9606
577 4AIZ 2 B V2-17 PROTEIN 9606
578 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
579 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
580 5L21 2 B VHH-C2 30538
581 5IT2 1 H heavy chain 9606
582 5IT2 2 L light chain 9606
583 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
584 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
585 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
586 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
587 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
588 2W59 1 A, B IGY FCU3-4 9031
589 5FWO 1 A NANOBODY 9844
590 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
591 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
592 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
593 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
594 4L1H 1 A Ig kappa chain V-I region Rei 9606
595 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
596 5MO3 3 L Fab of monoclonal antibody, light chain 10090
597 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
598 5GZ0 1 A, C FM329 light chain 1383439
599 5GZ0 2 B, D FM329 heavy chain 1383439
600 6DW2 1 A 6078 Fab light chain 9606
601 6DW2 2 B 6078 Fab heavy chain 9606
602 3B9V 1 A, B, C, D heavy chain variable domain 9606
603 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
604 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
605 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
606 6BQB 1 L MGG4 Fab light chain 9606
607 6BQB 2 H MGG4 Fab heavy chain 9606
608 4PUB 1 H DX-2930 HEAVY CHAIN 9606
609 4PUB 2 L DX-2930 LIGHT CHAIN 9606
610 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
611 6B14 2 L Light chain of Fab BL3-6S97N 10090
612 5N88 1 A, H VH59 antibody 9606
613 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
614 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
615 5TEZ 4 I TCR F50 alpha chain 9606
616 5TEZ 5 J TCR F50 beta chain 9606
617 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
618 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
619 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
620 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
621 5GS3 1 A, H diabody protein 9606
622 3BD3 1 A, B catalytic antibody 10090
623 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
624 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
625 2OTU 1 A, C, E, G Fv light chain variable domain 10090
626 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
627 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
628 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
629 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
630 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
631 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
632 5VKD 2 H Fab Heavy Chain 9606
633 5VKD 3 L Fab light chain 9606
634 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
635 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
636 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
637 5XHG 1 A, C polypeptide(L) 10090
638 5XHG 2 B, D polypeptide(H) 10090
639 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
640 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
641 5L8J 2 B New antigen receptor variable domain 168098
642 3UYR 1 H antibody Fab heavy chain 10090
643 3UYR 2 L antibody Fab light chain 10090
644 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
645 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
646 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
647 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
648 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
649 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
650 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
651 3OAZ 2 K, L Fab 2G12, light chain 9606
652 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
653 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
654 1T6V 2 N, O novel antigen receptor 7801
655 1ZAN 1 L Fab AD11 Light Chain 10116
656 1ZAN 2 H Fab AD11 Heavy Chain 10116
657 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
658 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
659 6CJK 1 A, C Immunoglobulin Fab light chain 9986
660 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
661 4N0Y 1 H IGH526 Heavy Chain 9606
662 4N0Y 2 L IGH526 Light Chain 9606
663 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
664 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
665 5MTH 1 A, H antibody Fab heavy chain 10090
666 5MTH 2 B, L antibody Fab light chain 10090
667 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
668 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
669 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
670 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
671 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
672 1RZF 1 L Fab E51 light chain 9606
673 1RZF 2 H Fab E51 heavy chain 9606
674 4N1C 1 A, B immunoglobulin variable light chain domain 9606
675 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
676 4KTE 2 L GE148 Light Chain Fab 9544
677 5I8O 1 H HMM5 antibody heavy chain 9606
678 5I8O 2 L HMM5 antibody light chain 9606
679 4OUO 1 A anti Bla g 1 scFv 9031
680 4JG0 1 L Fab light chain 9606
681 4JG0 2 H Fab heavy chain 9606
682 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
683 4YGV 2 B, L aDabi-Fab2a light chain 9606
684 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
685 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
686 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
687 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
688 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
689 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
690 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
691 3EO0 1 A, C GC-1008 Fab Light Chain 10090
692 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
693 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
694 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
695 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
696 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
697 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
698 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
699 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
700 6FUR 2 B, D Human F11 T-Cell Receptor 9606
701 4POU 2 B VHH Antibody 9844
702 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
703 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
704 6J5D 2 H antibody heavy chain 10090
705 6J5D 3 L antibody light chain 10090
706 4FQI 3 H antibody CR9114 heavy chain Fab 9606
707 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
708 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
709 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
710 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
711 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
712 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
713 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
714 4JHA 2 L D25 light chain 9606
715 6B9Z 1 A Trastuzumab Fab light chain 10090
716 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
717 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
718 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
719 4PTT 1 A Antibody pn132p2C05, light chain 9606
720 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
721 6H70 2 C, D Nanobody (VHH) Nano-62 30538
722 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
723 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
724 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
725 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
726 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
727 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
728 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
729 2P42 2 B, D ANTIBODY CAB-RN05 9838
730 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
731 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
732 6CPH 1 D TCR alpha chain 9606
733 6CPH 2 E TCR beta chain 9606
734 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
735 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
736 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
737 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
738 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
739 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
740 4DGV 1 H HCV1 Heavy Chain Fab 9606
741 4DGV 2 L HCV1 Light Chain 9606
742 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
743 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
744 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
745 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
746 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
747 5TH2 1 A, C cetuximab Fab, light chain 10090
748 5TH2 2 B, D cetuximab Fab, heavy chain 10090
749 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
750 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
751 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
752 5I8K 1 L HHH1 Fab Light chain 9606
753 5I8K 2 H HHH1 Fab Heavy chain 9606
754 4QLR 1 A, B Llama nanobody n02 VH domain 9844
755 5J56 2 B VHH single chain antibody V1C7 30538
756 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
757 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
758 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
759 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
760 1YNL 1 L Ig gamma light chain 10090
761 1YNL 2 H Ig gamma heavy chain 10090
762 6NRQ 1 A, C Defective proboscis extension response 10, isoform A 7227
763 6NRQ 2 B, D Dpr-interacting protein alpha, isoform A 7227
764 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
765 5EPM 2 B, F Antibody Fab fragment light chain 10090
766 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
767 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
768 5VH5 1 A Infliximab Fc 10090
769 3UMT 1 A scFv heavy chain and light chain 10090
770 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
771 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
772 4NUJ 1 A PGT152 light chain 9606
773 4NUJ 2 B PGT152 heavy chain 9606
774 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
775 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
776 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
777 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
778 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
779 3U2S 2 B, L PG9 light chain 9606
780 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
781 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
782 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
783 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
784 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
785 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
786 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
787 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
788 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
789 4NUG 1 L PGT151 light chain 9606
790 4NUG 2 H PGT151 heavy chain 9606
791 3IU4 1 H chP3 Fab heavy chain 10090
792 3IU4 2 L chP3 Fab light chain 10090
793 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
794 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
795 6J5F 2 H antibody heavy chain 10090
796 6J5F 3 L antibody light chain 10090
797 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
798 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
799 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
800 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
801 1P7K 1 A, L antibody light chain FAB 10090
802 1P7K 2 B, H antibody heavy chain FAB 10090
803 4NBX 2 B A20.1 VHH 9844
804 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
805 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
806 3RVV 2 C 4C1 - light chain 10090
807 3RVV 3 D 4C1 - heavy chain 10090
808 4HEP 2 G vHH17 domain 9844
809 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
810 3P0Y 2 H Fab DL11 heavy chain 9606
811 3P0Y 3 L Fab DL11 light chain 9606
812 4NPY 1 A, L germline PGT121 light chain Fab 9606
813 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
814 6ANA 2 H LL2 Fab Heavy Chain 10090
815 6ANA 3 L LL2 Fab Light Chain 10090
816 5IBU 1 B, L 6652 Light Chain 9606
817 5IBU 2 G, H 6652 Heavy Chain 9606
818 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
819 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
820 5VPL 2 C 4C1 - LIGHT CHAIN 10090
821 5VPL 3 D 4C1 - HEAVY CHAIN 10090
822 6AOD 1 A FXIa Antibody FAB Light Chain 9606
823 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
824 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
825 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
826 2YPV 2 H FAB 12C1 10090
827 2YPV 3 L FAB 12C1 10090
828 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
829 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
830 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
831 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
832 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
833 4JY5 1 L PGT122 light chain Fab 9606
834 4JY5 2 H PGT122 heavy chain Fab 9606
835 6ELE 1 A, H fAB heavy chain 9606
836 6ELE 2 B, L fAB light chain 9606
837 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
838 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
839 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
840 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
841 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
842 6B5R 1 H CIS42 Fab Heavy chain 9606
843 6B5R 2 L CIS42 Fab Light chain 9606
844 5IML 2 B Nanobody 9835
845 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606
846 3NAC 1 L Fab15 Mut7 light chain 9606
847 3NAC 2 H Fab15 Mut7 heavy chain 9606
848 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
849 3A6C 2 H IG VH, anti-lysozyme 10090
850 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
851 2DQD 2 H Ig VH,anti-lysozyme 10090
852 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
853 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
854 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
855 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
856 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
857 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
858 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
859 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
860 1Q72 1 L Fab M82G2, Light chain 10090
861 1Q72 2 H Fab M82G2, Heavy chain 10090
862 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
863 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
864 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
865 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
866 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
867 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
868 4YHO 1 H aDabi-Fab3 heavy chain 9606
869 4YHO 2 L aDabi-Fab3 light chain 9606
870 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
871 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
872 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
873 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
874 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
875 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
876 4DGY 1 H HCV1 Heavy Chain Fab 9606
877 4DGY 2 L HCV1 Light Chain 9606
878 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
879 3A67 2 H IG VH, anti-lysozyme 10090
880 2APB 1 A T-cell receptor beta chain V 10116
881 2APX 1 A T cell receptor beta chain V 10116
882 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
883 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
884 6EH6 2 B Human T Cell Receptor BetaChain 9606
885 5EN2 1 A GD01 heavy chain 10090
886 5EN2 2 B GD01 light chain 10090
887 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
888 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
889 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
890 1J1X 2 H Ig VH,anti-lysozyme 10090
891 5L8K 2 B New antigen receptor variable domain 168098
892 5M2J 2 D Anti-(ED-B) scFV 9606
893 3MXW 2 L 5E1 light chain 9606
894 3MXW 3 H 5E1 heavy chain 9606
895 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
896 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
897 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
898 2DQC 2 H Ig VH,anti-lysozyme 10090
899 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
900 1J1O 2 H Ig VH,anti-lysozyme 10090
901 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
902 3EO9 1 L Efalizumab Fab fragment, light chain 9606
903 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
904 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
905 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
906 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
907 4M62 2 H, I GEP2 FV heavy chain 9606
908 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
909 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
910 5IVO 1 A BC2-nanobody 30538
911 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
912 1J1P 2 H Ig VH,anti-lysozyme 10090
913 6N35 1 K, L Fab 2G12 light chain 9606
914 6N35 2 H, M Fab 2G12 heavy chain 9606
915 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
916 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
917 4NBZ 2 B, D A26.8 VHH 9844
918 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
919 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
920 5WUV 1 L light chain 9606
921 5WUV 2 H heavy chain 9606
922 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
923 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
924 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
925 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
926 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
927 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
928 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
929 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
930 5AYU 2 H Ig VH,anti-lysozyme 10090
931 4JM4 1 H PGT 135 Heavy Chain Fab 9606
932 4JM4 2 L PGT 135 Light Chain Fab 9606
933 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
934 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
935 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
936 3A6B 2 H IG VH, anti-lysozyme 10090
937 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2